Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen R, Allen. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Photoplethysmography and its application in clinical physiological. Science 2007; 213: 220-222
Aliot E, Brandes A, Eckardt L, Elvan A, Gulizia M, Heidbuchel H, Kautzner J, Mont L, Morgan J, Ng A, Szumowski L, Themistoclakis S, Van Gelder IC, Willems S, Kirchhof P.
Redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial. Eur Heart J 2015; 36: 255-256
Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J. Twenty-five years in the making:
flecainide is safe and effective for the management of atrial fibrillation. Europace 2011;
13: 161-173
Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF Consortium. J Am Heart Assoc 2013; 2: 102-112
Arentz T, Haegeli LM, Sanders P, Weber R, Neumann FJ. Highdensity mapping of spontaneous pulmonary vein activity initiating atrial fibrillation in humans. J Cardiovasc Electrophysiol 2007; 18: 31-38
Armour J.A, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and Microscopic Anatomy of the Human Intrinsic Cardiac Nervous System. Anat Rec 1997; 247: 289-298
Arora R, Ulphani JS, Villuendas R, Ng J, Harvey L, Thordson S, Inderyas F, Lu Y, Gordon D, Denes P, Greene R, Crawford S, Decker R, Morris A, Goldberger J, Kadish
AH. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium. Am J Physiol Heart Circ Physiol 2008; 294: 134-144
Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Albert Schömig A, Schmidt G. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation 2003;
108: 1221-1226
Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart Rate Turbulence: Standards of Measurement, Physiological Interpretation and Clinical Use. Am Coll Cardiol 2008; 52: 1353-1365
Benjamin EJ, Levy D, Vaziri SM, Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a racially and geographically diverse Population-based cohort: The framingham heart Study. JAMA 1994; 271: 840-844
Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002; 105: 2753-2759
Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction.
Circulation 1992; 85: 164-171
Bigger JT, La RM, Steinman RC, Fleiss JL, Rottman JN, Rolnitzky LM, Schwartz PJ.
Comparison of baroreflex sensitivity and heart period variability after myocardial infarction. J Am Coll Cardiol 1989; 4: 1511-1518
Bigger JT, Rolnitzky LM, Steinman RC, Fleiss JL. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy. J Am Coll Cardiol 1994; 23: 733-740
Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66: 874-880
Bonnemeier H, Wiegand UK, Friedlbinder J, Schulenburg S, Hartmann F, Bode F,Katus HA, Richardt G. Reflex cardiac activity in ischemia and reperfusion: heart rate turbulence in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. Circulation 2003; 108: 958-964
Bradley DJ, Shen WK. Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation. Clin Pharmacol Ther 2007; 81: 284-287
Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 839-845
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up. Europace 2012;
14: 528-606
Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I.
Treatment of atrial fi brillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2:
349-361
Camm AJ, Capucci A, Hohnloser SH, Torp-Pedersen C, Van Gelder IC, Mangal B, Beatch G. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent onset atrial fibrilllation. J Am Coll Cardiol 2011; 57:
313-321
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. ACC/AHA/ESC guidelines for the management of atrial fibrillation. Europace 2010; 12: 1360-1420
Camm AJ, Marek Malik M, London, Bigger JT, Breithardt G, Münster, Cerutti S, Cohen RJ, Coumel P, Fallen EL, Hamilton, Kennedy HL, Kleiger RE, Schmidt G. Heart rate variability Standards of measurement. physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-381
Cheng X, Li X, He Y, Liu X, Wang G, Cheng L, Hu J. Catheter ablation versus anti arrhythmic drug therapy for the management of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol 2014; 41: 267-272
Chess GF, Tam RMK, Calaresu FR. Influence of cardiac neural inputs on rhythmic variations of heart period in the cat. Am J Physiol 1975; 228: 775-780
Chierchia GB, De Asmundis C, Müller-Burri SA, Sarkozy A, Capulzini L, Paparell G, Chierchia S, Roos M, Brugada P. Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation. Europace 2009; 11: 445-449
Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EL, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129: 837-847
Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.
Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Heart Rhythm 2013; 10: 1792-1799
Connolly SJ, Ezekowitz MD, Yusuf s, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L. Dabigtran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151
Cotter G, Blatt A, Kaluski E, Metzkor-Cotter E, Koren M, Litinski I, Simantov R, Moshkovitz Y. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized placebo-controlled study. Eur Heart J 1999; 20: 1833-1842
Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996; 94: 1600-1606
Dorian P, Cvitkovic SS, Kerr CR, Crystal E, Gillis AM, Guerra PG, Mitchell LB, Roy D, Skanes AC, Wyse DG. A novel. Simple scale for assessing the symptom severity of atrial fibrillation at the bedside: The CCS-SAF Scale. Can J Cardiol 2006; 22: 383-386
Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM, Mitchell LB, Roy D, Skanes AC, Rose MS, Wyse DG. Validation of a new simple scale to measure symptoms in atrial fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale. Circ Arrhythm Electrophysiol 2009; 2: 218-224
Eitel C, Koch J, Sommer P, John S, Kircher S, Bollmann A, Arya A, Piorkowski C, Hindricks G. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation. Europace 2013; 15: 1587-1593
Ewing DJ, Martin CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-498
Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis AM, Sheldon RS, Fick GH, Duff HJ. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007; 50: 2275-2284
Fedida D, Orth PM, Chen JY, Lin S, Plouvier B, Jung G, Ezrin AM, Beatch GN. The mechanism of atrial antiarrhythmic action of RDS1235. J Cardiovasc Elektrophsiol 2005;
16: 1227-1238
Francis J, Watanabe MA, Schmidt G. Heart rate turbulence: a new predictor for risk of sudden cardiac death. Ann Noninvasive Electrocardiol 2005; 10: 102-109
Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 2011; 13: 329-345
Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 2016; 37: 2478-2487
Fürnkranz A, Chun J, Schmidt B Ouyang F, Kuck KH. Kryoballon Pulmonalvenen-isolation zur Behandlung von paroxysmalem Vorhofflimmern. Au J Cardiol 2010; 17:
154-156
Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S.
ACC/AHA/ESC 2006 guidelines for Management of Patients with atrial fibrillation-executive summary. Eur Heart J 2006; 27: 1979-2030
Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT Jr, Camm AJ, Schwartz PJ, Malik M. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest: The
Autonomic Tone and Reflexes After Myocardial Infarction substudy. Am J Cardiol 2002;
89: 184-190
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al Khalidi HR, Ansell J, Atar D, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992
Haegeli LM, Duru F, Lockwood EE, Lüscher TF, Sterns LD, Novak PG, Leather RA.
Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation. Postgrad Med J 2010; 86: 395-398
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666
Hales S. Statical Essays. In: Innys W, Manby R, Woodward T, peele J, eds. London:
1735
Hallstrom AP, Stein PK, Schneider R, Hodges M, Schmidt G, Ulm K. Characteristics of heart beat intervals and prediction of death. Int J Cardiol 2005; 100: 37-45
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146: 857-867
Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, Pürerfellner H. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrythm Electrophysiol 2010; 3: 141-147
Hirsh JA, Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am J Physiol 1981; 241: 620-629
Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360: 668-678
Hohnloser SH, Klingenheben T, Zabel M, Li YG. Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction. Pacing Clin Elektrophysiol 1997; 20:
2594-2601
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P.
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevension of stroke in patients with atrial fibrillation: a randomised non inferiority trial. Lancet 2009;
374: 534-542
Hon EH, Lee ST. Electronic evaluations of the fetal heart rate patterns preceding fetal death, further observations. Am J Obstet Gynecol 1965; 87: 814-826
Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. Effect of intensity of oral anticagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243
Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004; 35: 1647-1651
Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Clementy J, Haissaguerre M.
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.
Circulation 2008; 118: 2498-2505
Jokinen V, Tapanainen JM, Seppanen T, Huikuri HV. Temporal changes and prognostic significance of measures of heart rate dynamics after acute myocardial infarction in the beta-blocking era. Am J Cardiol 2003; 92: 907-912
Jons C, Raatikainen P, Gang UJ, Huikuri HV, Joergensen RM, Johannesen A, Dixen U, Messier M, MCnitt S, Thomsen PE. Autonomic dysfunction and new onset atrial fibrillation in patients with left ventricular systolic dysfunction after acute myocardial infarction: a CARISMA substudy. J Cardiovasc Electrophysiol 2010; 21: 983-990
Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, Kelesidis KM. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent oncet atrial fibrillation and atrial flutter. Int J Cardiol 2007; 118: 321-325
Kapa S, Venkatachalam KL, Asirvatham SJ. 2010. The autonomic nervous system in cardiac electrophysiology: an elegant interaction and emerging concepts. Cardiol Rev 2010; 18: 275-284
Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol 2008; 102: 330-334
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized
by the German Atrial Fibrillation Competence Network and the European Heart Rhythm Association. Europace 2007; 9: 1006-1023
Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA Consensus Conference. Research perspectives in AF. Eur Heart J 2009; 30: 2969-2977
Kirchhof P, Breithardt G, Camm AJ, Crijns HJ, Kuck KH, Vardas P, Wegscheider K.
Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Am Heart J 2013; 166: 442-448
Kirchhof P, Goette A, Gulba D, Hindricks G, Hohnloser SH. Kommentar zu den Leitlinien der ESC zum Vorhofflimmern. Kardiol 2012; 6: 12-27
Kirchhof P, Stefano Benussi S, Kotecha D, Ahlsson, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Putte BV, Vardas P. The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2893–
2962
Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and ist association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-262
Klein AL, Grimm RA, Murray RD, Apperson-Hansen C, Asinger RW, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF. Use of transesophageal echocardiography to guide cardioversion in patients with atriall fibrillation. N Engl J Med 2001; 344: 1411-1420
Kober L, Torp-Pedersen C, McMurray JJ, Gotzsche O, Levy S, Crijns H, Amlie J,
Carlsen J. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008; 358: 2678-2687
Kochiadakis GE, Igoumenidis NE, Parthenakis FI, Chlouverakis GI, Vardas PE.
Amiodarone versusnpropafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. J Am Coll Cardiol 1999; 33: 966-971
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. EUROASPIRE III:
a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16:
121-137
Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, Sadowski J, Sobczyk D, Bochenek A, Toft E. Vernakalant hydeochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double blind, placebo controlled trial. Circ Arhythm Electrophysiol 2009; 2: 652-659
Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KRJ, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C. The FIRE AND ICE Investigators.
Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med 2016; 374: 2235-2245
La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT Jr, Camm AJ, Schwartz PJ. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials. Circulation 2001; 103: 2072-2077
La Rovere MT, Schwartz PJ. Baroreflex sensitivity as a cardiac and arrhythmia mortality risk stratifier. Pacing Clin Electrophysiol 1997; 20: 2602-2613
Levy MN. Experimental basis and clinical implications. In: Schwartz PJ, eds. Vagal control of the heart. Armonk - New York: Future, 1994: 173-205
Lewalter T, Dobreanu D, Proclemer A, Marinskis G, Pison L, Blomstrom Lundqvist C.
Atrial fibrillation ablation techniques. Europace 2012; 4: 1515-1517
Lin LY, Hwang JJ, Lai LP, Chan HL, Du CC, Tseng YZ, Lin JL. Restoration of heart rate turbulence by titrated beta-blocker therapy in patients with advanced congestive heart failure: positive correlation with enhanced vagal modulation of heart rate. J Cardiovasc Electrophysiol 2004; 15: 752-756
Löllgen H. Herzfrequenzvariabilität. Dt Ärtzebl 1999; 96: 2029-2032
Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Finocchiaro ML, Bernasconi R, Cappiello E. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability. Am J Cardiol 1992; 70: 1028-1034
Lown B, Verner RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:
1165-1170
Maier B, Thimme W, Schoeller R, Fried A, Behrens S, Theres H. Improved therapy and outcome for patients with acute myocardial infarction-data of the Berlin Myocardial Infarction Registry from 1999 to 2004. Int J Cardiol 2008; 130: 211-219
Makikallio TH, Barthel P, Schneider R, Makikallio TH, Barthel P, Schneider R. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005; 26: 762-769
Malik M, Farrell T, Cripps T, Camm AJ. Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques. Eur Heart J 1989; 10:
1060-1074
Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492
McNamara RL, Bass EB, Miller MR, Segal JB, Goodman SN, Kim NL, Robinson KA, Powe NR. Management of new onset atrial fibrillation. Med 2008; 168: 581-586
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125
Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959; 58: 59-70
Montano N, Cogliati C, Porta A, Pagani M, Malliani A, Narkiewicz K, Abboud FM, Birkett C, Somers VK. Central vagotonic effects of atropine modulate spectral oscillations of sympathetic nerve activity. Circulation 1998; 14: 1394-1399
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338
Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11: 423-434
Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Levy S, Crijns HJ. Atrial fibrillation management:
a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26: 2422-2434
Nokin P, Clinet M, Schoenfeld P. Cardiac beta-adrenoceptor modulation by amiodarone.
Biochem Pharmacol 1983; 32: 2473-2477
Olsson SB, Carlson J, Holm M. Atrioventricular nodal function in atrial fibrillation: what is the optimum ventricular rate. In: Murgatroyd FD, Camm AJ, eds. Nonpharmacolgical management of atrial fibrillation. Armonk - New York: Futura,1996: 55-64
Ortak J, Weitz G, Wiegand UK, Bode F, Eberhardt F, Katus HA, Richardt G, Schunkert H, Bonnemeier H. Changes in heart rate, heart rate variability, and heart rate turbulence during evolving reperfused myocardial infarction. Pacing Clin Electrophysiol 2005; 28:
227-232
Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular mani-festations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol 2007; 49: 71-81
Ozaydin M, Turker Y, Varol E, Alaca S, Erdogan D, Yilmaz N, Dogan A. Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis. Int J Cardiovasc Imaging 2010; 26: 547-552
Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Gersh BJ, Hammill SC, Shen WK. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344: 1043-1051
Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-193
Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A,
Manguso F, Santinelli V. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-2347
Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O.
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109: 327-334
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrilltion. N Engl J Med 2011;
365: 883-891
Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000;
259: 353-382
Piorkowski C, Sih H, Sommer P, Miller SP, Gaspar T, Teplitsky L, Hindricks G. First in human validation of impedance-based catheter tip-to-tissue contact assessment in the left atrium. J Cardiovasc Electrophysiol 2009; 20: 1366-1373
Pomeranz M, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: 151-153
Providencia R, Albenque JP, Combes S, Bouzeman A, Casteigt B, Combes N, Narayanan K, Marijon E, Boveda S. Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Heart 2014; 100: 324-335